The global Internal Nasal Dilators Market Growing Adoption of Digital Technologies
Internal nasal dilators are medical devices that
are used to open nasal passages by protruding the nasal walls. They work by
utilizing the anatomy of the nasal valve and lateral walls to gently widen the
nasal passages thereby making breathing easier. Some key advantages of internal
nasal dilators include ease of use, comfort, and effectiveness in improving
nasal breathing. The need for such products arises due to the growing
prevalence of various breathing disorders like snoring and sleep apnea.
Market key trends:
The adoption of digital technologies is expected to be a major trend in the internal nasal dilators market. Key players in the market are increasingly focusing on development of digital nasal dilators that integrate sensors and electronic components to provide real-time data monitoring and feedback. For instance, in 2021, SnoreCo announced the launch of a new digital nasal dilator called ‘TheraNest Smart’. It uses an integrated biosensor and Bluetooth connectivity to track breathing patterns, snoring levels, sleep quality metrics and provide personalized data analysis and recommendations via a mobile app. Such digitized offerings are poised to witness higher demand, especially among self-quantifying users, as they provide greater therapy insights and convenience compared to conventional dilator strips. This is expected to spur innovative product launches and boost overall market revenues over the forecast period.
Segment Analysis
The global Internal Nasal Dilators market is dominated by the premoulded segment due to its ease of use, comfortability, and effectiveness. Premoulded nasal dilators do not require any manual fitting as compared to customizable nasal devices. This makes premoulded dilators very convenient for daily or nightly use for treating conditions like snoring and sleep apnea.
Key Takeaways
The global Internal Nasal Dilators market is expected to witness high growth over the forecast period of 2023 to 2030. Rapidly ageing population globally which is more susceptible to sleep apnea and other breathing issues during sleep is driving the demand for nasal dilators.
The North American region currently dominates the Internal Nasal Dilators market due to high awareness levels about sleep disorders and availability of advanced treatment options like nasal dilators. According to the Centers for Disease Control and Prevention (CDC), over 25 million Americans are estimated to have sleep apnea. Increasing diagnosis and treatment rates of sleep disorders in the US is supporting the growth of the nasal dilators market in the region.
Key players operating in the Internal Nasal Dilators market are Becton, Dickinson and Company, Gerresheimer AG, Sharps Technology, Inc., Cardinal Health, lomMedical, MHC Medical Products, LLC, Sol-Millennium, UltiMed Inc., VOGT MEDICAL, Retractable Technologies, Inc., Dmcmedical, BIOCORP, Hindustan Syringes & Medical Devices Ltd, Owen Mumford Ltd., B. Braun SE, Terumo Europe NV, Smiths Group plc, Merit Medical Systems, Nipro Corporation, GPC Medical Ltd., AdvaCare Pharma. Major players are focusing on new product launches and geographical expansion to strengthen their market presence. For instance, Becton, Dickinson and Company launched nasal dilators under the Comfortsure and Rhinosure brands in 2019 to target sleep disorder patients.

Comments
Post a Comment